Medicine and Dentistry
Inflammatory Bowel Disease
100%
Colitis
66%
Ulcerative Colitis
61%
Systematic Review
61%
Disease Activity
55%
Outcome Assessment
33%
Crohn's Disease
33%
Faecal Calprotectin
27%
Surgeon
27%
Pathologist
27%
Epidemiologist
27%
C Reactive Protein
27%
Nurse
27%
Patient with Inflammatory Bowel Disease
27%
Biological Marker
27%
Ulcer
27%
Diseases
27%
Combination Therapy
16%
Observational Study
11%
Independent Reviewer
5%
Patient-Reported Outcome
5%
Population Exposure
5%
Adverse Event
5%
Decision Making
5%
Pharmacology, Toxicology and Pharmaceutical Science
Ulcerative Colitis
75%
Remission
44%
Tofacitinib
41%
Cohort Study
38%
Inflammatory Bowel Disease
33%
Ustekinumab
33%
Colitis
30%
Combination Therapy
25%
Adverse Event
21%
Observational Study
16%
Calgranulin
16%
Disease Activity
13%
Interleukin 23 Receptor
8%
Crohn's Disease
8%
Population Exposure
8%
Receptor Antagonist
8%
Clinical Trial
8%
Interleukin 12
8%
Biological Product
8%
Nursing and Health Professions
Real-World Evidence
33%
Outcome Assessment
33%
Systematic Review
33%
Inflammatory Bowel Disease
33%
Combination Therapy
16%
Patient-Reported Outcome
5%
Crohn's Disease
5%
Ulcerative Colitis
5%
Population Exposure
5%
Filter
5%
CINAHL
5%
Independent Reviewer
5%
Adverse Event
5%
